AstraZeneca PLC (AZN)

1,644.0 +3.0 (+0.18%)
Close SEK Disclaimer

AZN Financial Summary

AstraZeneca PLC reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 457 million compared to USD 286 million a year ago. Revenue was USD 12,679 million compared to USD 10,879 million a year ago. Net income was USD 2,179 million compared to USD 1,803 million a year ago. Basic earnings per share from continuing operations was USD 1.41 compared to USD 1.16 a year ago. Diluted earnings per share from continuing operations was USD 1.4 compared to USD 1.16 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
AZN
Gross margin TTM 82.5%
Operating margin TTM 23.53%
Net Profit margin TTM 13.3%
Return on Investment TTM 13.08%
Total Revenue
Net Income
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Revenue 12,679 12,024 11,492 11,416
Gross Profit 10,481 9,729 9,437 9,499
Operating Income 3,310 2,034 2,533 2,602
Net Income 2,179 960 1,374 1,818
Clear All
0Selected
Please try another search
AZN
Quick Ratio MRQ 0.66
Current Ratio MRQ 0.89
LT Debt to Equity MRQ 72.93%
Total Debt to Equity MRQ 92.65%
Total Assets
Total Liabilities
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Assets 102,293 101,119 96,086 96,543
Total Liabilities 64,792 61,953 58,865 59,127
Total Equity 37,501 39,166 37,221 37,416
Clear All
0Selected
Please try another search
AZN
Cash Flow/Share TTM 6.26
Revenue/Share TTM 30.71
Operating Cash Flow 8.60%
Cash
Net Change in Cash
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Cash From Operating Activities 2,486 2,380 3,114 1,718
Cash From Investing Activities -2,413 -1,077 -1,221 -520
Cash From Financing Activities 2,028 -291 -2,726 -1,519
Net Change in Cash 2,055 1,018 -852 -357
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles